Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Administration of Antidepressant Without Justified Diagnosis or Symptoms

North Sacramento, California Survey Completed on 07-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a resident was administered an antidepressant medication, escitalopram, without a corresponding medical diagnosis or documented behavioral symptoms to justify its use. The resident was admitted with a diagnosis of anxiety disorder, but there was no diagnosis of depression documented in the Minimum Data Set (MDS), physician progress notes, or the problem list. The MDS assessment indicated no symptoms or behaviors of depression, and the depression screening was negative. Despite this, a physician's order was written for escitalopram with the indication of depression, citing 'verbalized sadness' as the target behavior, but the Treatment Administration History Record showed that this behavior did not occur during the review period. Further review of the Medication Regimen Review raised concerns about the lack of a documented indication for escitalopram, noting that depression was not listed in the resident's problem list and the history and physical stated the depression screening was negative. Interviews with facility staff, including the MDS Coordinator, a licensed nurse, and the DON, confirmed that the resident did not have a diagnosis of depression and that no target behaviors were observed or documented. The facility's policy on comprehensive care planning was reviewed, but a policy on unnecessary medications was requested and not provided.

An unhandled error has occurred. Reload 🗙